Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Syngenta fends off Monsanto takeover bid

27 August 2015 Business

Unmoving objection to merger leads US giant to drop pursuit

Job cuts at Lundbeck and DSM

27 August 2015 Business

Each cutting around 1000 roles in reorganisation efforts

Drugs in a class of their own

27 August 2015 Editorial

Business leader: New drug types need careful regulation to reward innovation while protecting patients

Berry plastics to buy Avintiv for $2.5bn

4 August 2015 Business

Deal helps Berry diversify from food packaging into speciality medical materials

AstraZeneca sells off drugs to streamline portfolio

3 August 2015 Business

Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus

Lightweight composites drive Solvay to buy Cytec

31 July 2015 Business

$5.5bn deal launches Solvay into aerospace materials business

Biogen to develop gene therapies with AGTC

29 July 2015 Business

$1bn deal gives Biogen rights to one clinical candidate and several earlier-stage programmes for rare eye diseases

Hikma boosts generics with Roxane buyout

29 July 2015 Business

Acquiring the Boehringer Ingelheim subsidiary expands Hikma’s presence in US generics market

Celgene to buy immune-inflammatory specialist Receptos

29 July 2015 Business

$7.2bn deal further strengthens Celgene’s position in immunology

Three dead in Chinese petrochemical plant fire

27 July 2015 Business

Further four workers injured after leaking oil ignited at Qingyang Petrochemical plant in Gansu province

Taking responsibility seriously

23 July 2015 Editorial

Business leader: Companies have a duty to be proactive when it comes to sustainability

An unsustainable hypocrisy

21 July 2015 Business

Social responsibility should extend through the whole supply chain, not just be a tool to put pressure on feedstock suppliers

Thermo Fisher to buy Alfa Aesar chemical supplies

8 July 2015 Business

Research chemicals business no longer a strategic fit for owner Johnson Matthey

Celgene backs immunotherapy with Juno collaboration

8 July 2015 Business

$1bn investment in 10-year CAR-T cell partnership for cancer treatments

Blast kills six at South Korean chemical plant

7 July 2015 Business

One further worker injured as tank explodes during welding work

Job cuts at Allergan and Transgene

3 July 2015 Business

Allergan is shedding 300 staff at former Actavis site in Iceland, while Transgene is closing its French manufacturing plant with loss of 120 jobs

Fracking prohibited in New York state and Lancashire

2 July 2015 Business

Local US and UK rulings prohibit shale oil drilling and exploration

What's in a name?

30 June 2015 Editorial

Business leader: Why do companies attach abstract values to their names?

Collaboration, not competition

29 June 2015 Research

Organic chemist E J Corey talks to Phillip Broadwith about awards, ambition and academic freedom

Missing the target

23 June 2015 In the Pipeline

There are plenty of things that small molecule drugs can’t touch, says Derek Lowe, and it’s not for want of trying

Opko deepens diagnostics with $1.5bn lab buyout

9 June 2015 Business

Taking over clinical diagnostics service provider BioReference Laboratories gives Opko a bigger avenue to distribute and market its diagnostic tests

Vertex nabs rights to cystic fibrosis molecules

9 June 2015 Business

Deal with Parion, worth up to $1bn, gives firm worldwide rights to investigational treatments that complement Vertex’s existing cystic fibrosis drugs

Takeda to consolidate vaccines business in Boston

4 June 2015 Business

Firm will close three recently-acquired US sites and shift operations to the growing pharmaceutical hub in Massachusetts

OM Group to be sold and split

2 June 2015 Business

Apollo Global Management will buy the firm for $1bn, then sell electronic materials business to Platform Specialty Products

Teva fined $1.2bn in pay-for-delay case

1 June 2015 Business

Company illegally blocked generic competition of sleep disorder drug, and settlement terms tighten up rules on anticompetitive behaviour